Embecta Corp (EMBC)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $366.02M
Last updated: Nov 17, 2026 at 11:05 AM ET
Embecta Corp (EMBC) Stock Forecast
Analysts expect Embecta (EMBC) to earn $1.76 per share in the fiscal year ending Sep 30, 2027, on revenue of $1.08B. Of 4 analysts, 0 rate the stock Buy or Strong Buy, 3 Hold and 1 Sell or Strong Sell, for a consensus of Sell. Over the last 30 days, 3 estimates for the fiscal year ending Sep 30, 2027 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 4 ratings average 3.50, inside the Sell band from 3.5 up to 4.5. Sell and Strong Sell make up 25% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 3 | 75.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 25.0% |
- Consensus
- Sell
- Total analysts
- 4
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Sep 30, 2027
- $1.76
- EPS consensus, revenue $1.08B
- Next report
- Nov 23, 2026
- Estimated
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Sep 30, 2027 | $1.76 | $1.75 to $1.77 | 4 | $1.08B | $1.08B to $1.08B | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.49 | $0.39 to $0.67 | 3 | $268.02M | $264.86M to $274.20M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 3 | 0 |
| Quarter ending Dec 31, 2026 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has risen 1.1% from $1.74.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | $1.76 | $1.76 | $1.76 | $1.76 | $1.74 | +1.3% |
| Quarter ending Dec 31, 2026 | $0.49 | $0.48 | $0.48 | $0.48 | $0.49 | +0.7% |
Frequently Asked Questions About EMBC
What is the EMBC stock forecast?
Consensus analyst estimates put Embecta's EPS at $1.76 for the fiscal year ending Sep 30, 2027, on revenue of $1.08B. The consensus rating from 4 analysts is Sell.
How do analysts rate EMBC stock?
Of 4 analysts covering Embecta, 0 rate it Strong Buy, 0 Buy, 3 Hold, 0 Sell and 1 Strong Sell, for a consensus of Sell.
What EPS do analysts expect from EMBC next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is $1.76, with estimates from $1.75 to $1.77 from 4 analysts.
What revenue do analysts expect from Embecta next year?
For the fiscal year ending Sep 30, 2027, the consensus revenue estimate is $1.08B, with estimates from $1.08B to $1.08B.
How many analysts cover EMBC?
4 analysts rate Embecta stock, and 4 analysts estimate its EPS for the fiscal year ending Sep 30, 2027.
EMBC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors